ReNeuron Group plc Company Profile

17:45 EDT 20th March 2018 | BioPortfolio

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our stem cell technologies into non-therapeutic areas such as drug discovery - our ReNcell product.We have proprietary stem cell technologies which we believe confer significant advantages over competitor technologies, in terms of our ability to generate stable cell lines with the characteristics necessary for commercial exploitation


10 Nugent Rd Surrey Research Park
United Kingdom


Phone: 44 (0)1483 302560
Fax: 44 (0)1483 534864

News Articles [318 Associated News Articles listed on BioPortfolio]

ReNeuron Group (RENE) - Consolidation confusion?

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron’s recent 100 for 1 share consolidation was a benign and cosmetic ‘tidy up’ of its historical capit...

ReNeuron Group (RENE) - Biblical aspirations

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron’s interim results for the six months to 30 September 2017 showcased a crucial juncture in the company’s ...

ReNeuron pleased to secure podium presentation for stroke data at US conference

Michael Hunt, CFO at ReNeuron Group Plc (LON:RENE) tells Proactive positive long-term data on their CTX cell therapy for stroke has been presented at the American Heart Association International Str...

ReNeuron presents positive data for CTX cell therapy candidate

Cell-based therapeutics developer ReNeuron Group announced on Friday that positive long-term data from the Phase II clinical trial - PISCES II -of its CTX cell therapy candidate for stroke disabili...

ReNeuron's Michael Hunt discusses very encouraging long-term stroke data

Michael Hunt, chief financial officer at ReNeuron Group Plc (LON:RENE) updates Proactive on their phase II clinical study treating stroke patients with its CTX stem cells. Hunt says the positive r...

ReNeuron's CTX cells play a part in positive artificial nerve tissue study

This is the first time ReNeuron's CTX cells have been combined with an engineered support to guide nerve repair

Big batches, big margins: Reneuron on off-the-shelf stem cells

Difficulty in scaling-up autologous cell therapies means margins are low says Reneuron, which is focused on off-the-shelf stem cell products.

'Lots to look forward to' as ReNeuron gets go-ahead for phase IIb stroke trial

Michael Hunt, CFO of ReNeuron Group Plc (LON:RENE),  tells Proactive they've been given the green light from US authorities to kick off a phase IIb study of its CTX cell therapy candidate for s...

PubMed Articles [1829 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement.

The success of fluorinated molecules in drug design has led medicinal chemists to search for new fluorine-containing substituents. A major recently developed group is the pentafluorosulfanyl group. Th...

Systemic granulomatous disease in dairy cattle during a dicyandiamide feeding trial.

Mature, in-calf, non-lactating, Friesian or Friesian-cross cows were fed dicyandiamide (DCD) at daily doses of 0.15 g/kg (Group 1; n=31), 0.45 g/kg (Group 2; n=21) and 0.75 g/kg (Group 3; n=12), as pa...

Clinical Trials [3526 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Companies [1599 Associated Companies listed on BioPortfolio]


ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "ReNeuron Group plc" on BioPortfolio

We have published hundreds of ReNeuron Group plc news stories on BioPortfolio along with dozens of ReNeuron Group plc Clinical Trials and PubMed Articles about ReNeuron Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReNeuron Group plc Companies in our database. You can also find out about relevant ReNeuron Group plc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record